IMC Chicago
MRNA icon

IMC Chicago’s Moderna MRNA Stock Holding History

IMC Chicago’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112M Buy
2,204,100
+269,300
+14% +$12.6M 0.04% 274
2025
Q4 		$57.1M Sell
1,934,800
-305,700
-14% -$8.31M 0.02% 453
2025
Q3 		$57.9M Buy
2,240,500
+583,700
+35% +$16.3M 0.02% 420
2025
Q2 		$45.7M Sell
1,656,800
-391,300
-19% -$10.3M 0.02% 414
2025
Q1 		$58.1M Buy
2,048,100
+522,100
+34% +$18.5M 0.03% 283
2024
Q4 		$63.5M Buy
1,526,000
+360,000
+31% +$17.2M 0.03% 287
2024
Q3 		$77.9M Buy
1,166,000
+195,300
+20% +$17.9M 0.04% 216
2024
Q2 		$115M Buy
970,700
+264,500
+37% +$33.5M 0.07% 138
2024
Q1 		$75.3M Sell
706,200
-155,500
-18% -$15.7M 0.05% 185
2023
Q4 		$85.7M Buy
861,700
+209,100
+32% +$17.6M 0.06% 165
2023
Q3 		$67.4M Buy
652,600
+41,000
+7% +$4.57M 0.06% 154
2023
Q2 		$74.3M Sell
611,600
-95,600
-14% -$12.8M 0.07% 132
2023
Q1 		$109M Sell
707,200
-371,000
-34% -$61.2M 0.13% 76
2022
Q4 		$194M Buy
1,078,200
+214,700
+25% +$35.1M 0.3% 36
2022
Q3 		$102M Buy
863,500
+13,200
+2% +$2M 0.13% 61
2022
Q2 		$121M Sell
850,300
-386,100
-31% -$55.2M 0.17% 48
2022
Q1 		$213M Sell
1,236,400
-477,100
-28% -$80.3M 0.21% 45
2021
Q4 		$435M Buy
1,713,500
+560,200
+49% +$164M 0.36% 32
2021
Q3 		$444M Buy
1,153,300
+330,100
+40% +$122M 0.47% 30
2021
Q2 		$193M Buy
823,200
+32,600
+4% +$5.83M 0.24% 51
2021
Q1 		$104M Buy
790,600
+19,700
+3% +$2.85M 0.15% 69
2020
Q4 		$80.5M Buy
770,900
+397,900
+107% +$40.3M 0.1% 87
2020
Q3 		$26.4M Buy
373,000
+52,500
+16% +$3.66M 0.04% 153
2020
Q2 		$20.6M Buy
320,500
+310,300
+3,042% +$17M 0.04% 151
2020
Q1 		$305K Buy
+10,200
New +$235K ﹤0.01% 787

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IMC Chicago's MRNA Position: Q1 2026 in Review

IMC Chicago sold out of Moderna (MRNA) in Q1 2026, closing a stake of 257,166 shares — an estimated $12M sold.

IMC Chicago first reported a position in MRNA in Q2 2020 and held it in 11 quarters. The position peaked at $15.4M in Q4 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • IMC Chicago reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 257,166 Moderna shares in Q1 2026, an estimated $12M.
  • IMC Chicago first reported a position in Moderna in Q2 2020 and held it in 11 quarters.
  • IMC Chicago's Moderna position peaked at $15.4M in Q4 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.